South Korea · Delayed Price · Currency is KRW Theseus Pharmaceuticals Statistics
Total Valuation
KRX:005930 has a market cap or net worth of KRW 450.15 trillion. The enterprise value is 363.45 trillion.
| Market Cap | 450.15T |
| Enterprise Value | 363.45T |
Important Dates
The last earnings date was Friday, July 25, 2025.
| Earnings Date | Jul 25, 2025 |
| Ex-Dividend Date | Jun 27, 2025 |
Share Statistics
KRX:005930 has 6.69 billion shares outstanding. The number of shares has increased by 4.66% in one year.
| Current Share Class | 5.88B |
| Shares Outstanding | 6.69B |
| Shares Change (YoY) | +4.66% |
| Shares Change (QoQ) | -1.31% |
| Owned by Insiders (%) | 4.35% |
| Owned by Institutions (%) | 41.76% |
| Float | 5.50B |
Valuation Ratios
The trailing PE ratio is 16.19 and the forward PE ratio is 13.81.
| PE Ratio | 16.19 |
| Forward PE | 13.81 |
| PS Ratio | 1.46 |
| PB Ratio | 1.13 |
| P/TBV Ratio | 1.21 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.03, with an EV/FCF ratio of 13.51.
| EV / Earnings | 12.01 |
| EV / Sales | 1.18 |
| EV / EBITDA | 5.03 |
| EV / EBIT | 13.12 |
| EV / FCF | 13.51 |
Financial Position
The company has a current ratio of 9.61, with a Debt / Equity ratio of 0.04.
| Current Ratio | 9.61 |
| Quick Ratio | 7.10 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.20 |
| Debt / FCF | 0.52 |
| Interest Coverage | 40.94 |
Financial Efficiency
Return on equity (ROE) is 7.96% and return on invested capital (ROIC) is 4.16%.
| Return on Equity (ROE) | 7.96% |
| Return on Assets (ROA) | 3.42% |
| Return on Invested Capital (ROIC) | 4.16% |
| Return on Capital Employed (ROCE) | 5.59% |
| Revenue Per Employee | 2.42B |
| Profits Per Employee | 237.57M |
| Employee Count | 127,372 |
| Asset Turnover | 0.62 |
| Inventory Turnover | 3.69 |
Taxes
In the past 12 months, KRX:005930 has paid 1.88 trillion in taxes.
| Income Tax | 1.88T |
| Effective Tax Rate | 5.68% |
Stock Price Statistics
The stock price has decreased by -17.88% in the last 52 weeks. The beta is 0.75, so KRX:005930's price volatility has been lower than the market average.
| Beta (5Y) | 0.75 |
| 52-Week Price Change | -17.88% |
| 50-Day Moving Average | 61,528.00 |
| 200-Day Moving Average | 57,326.00 |
| Relative Strength Index (RSI) | 60.65 |
| Average Volume (20 Days) | 22,173,024 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:005930 had revenue of KRW 308.59 trillion and earned 30.26 trillion in profits. Earnings per share was 4,256.11.
| Revenue | 308.59T |
| Gross Profit | 112.12T |
| Operating Income | 27.07T |
| Pretax Income | 33.03T |
| Net Income | 30.26T |
| EBITDA | 70.46T |
| EBIT | 27.07T |
| Earnings Per Share (EPS) | 4,256.11 |
Balance Sheet
The company has 100.73 trillion in cash and 14.03 trillion in debt, giving a net cash position of 86.70 trillion or 12,967.01 per share.
| Cash & Cash Equivalents | 100.73T |
| Total Debt | 14.03T |
| Net Cash | 86.70T |
| Net Cash Per Share | 12,967.01 |
| Equity (Book Value) | 399.56T |
| Book Value Per Share | 60,097.45 |
| Working Capital | 175.00T |
Cash Flow
In the last 12 months, operating cash flow was 78.11 trillion and capital expenditures -51,212.02 billion, giving a free cash flow of 26.90 trillion.
| Operating Cash Flow | 78.11T |
| Capital Expenditures | -51,212.02B |
| Free Cash Flow | 26.90T |
| FCF Per Share | 4,023.25 |
Margins
Gross margin is 36.33%, with operating and profit margins of 8.77% and 9.81%.
| Gross Margin | 36.33% |
| Operating Margin | 8.77% |
| Pretax Margin | 10.70% |
| Profit Margin | 9.81% |
| EBITDA Margin | 22.83% |
| EBIT Margin | 8.77% |
| FCF Margin | 8.72% |
Dividends & Yields
This stock pays an annual dividend of 1,460.00, which amounts to a dividend yield of 2.12%.
| Dividend Per Share | 1,460.00 |
| Dividend Yield | 2.12% |
| Dividend Growth (YoY) | 0.83% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -4.66% |
| Shareholder Yield | -2.62% |
| Earnings Yield | 6.72% |
| FCF Yield | 5.98% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 4, 2018. It was a forward split with a ratio of 50.
| Last Split Date | May 4, 2018 |
| Split Type | Forward |
| Split Ratio | 50 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |